Gyroscope Therapeutics and its gene therapy ... GTA005 is in phase 2 trials in two groups of patients with GA, an advanced form of 'dry' age-related macular degeneration (AMD) affecting the ...
French drugmaker Sanofi has made a $40 million investment in Gyroscope Therapeutics ... defined patient populations with GA, an advanced form of 'dry' AMD affecting the central portion of the ...
WILMINGTON, NEW CASTLE, DE, UNITED STATES, January 31, 2025 /EINPresswire / -- According to a recent report published by Allied <a target=_blank hr ...